243 related articles for article (PubMed ID: 16452487)
61. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
[TBL] [Abstract][Full Text] [Related]
62. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
[TBL] [Abstract][Full Text] [Related]
63. The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail.
Wonderlich ER; Williams M; Collins KL
J Biol Chem; 2008 Feb; 283(6):3011-3022. PubMed ID: 18073204
[TBL] [Abstract][Full Text] [Related]
64. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
65. Clusters of Structurally Similar MHC I HLA-A2 Molecules, Found with a New Method, Suggest Mechanisms of T-Cell Receptor Avidity.
Rashin AA; Jernigan RL
Biochemistry; 2016 Jan; 55(1):167-85. PubMed ID: 26600404
[TBL] [Abstract][Full Text] [Related]
66. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Papassavas AC; Barnardo MC; Bunce M; Welsh KI
Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
[TBL] [Abstract][Full Text] [Related]
67. Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules.
Sánchez LM; Chirino AJ; Bjorkman Pj
Science; 1999 Mar; 283(5409):1914-9. PubMed ID: 10206894
[TBL] [Abstract][Full Text] [Related]
68. Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
Storkus WJ; Salter RD; Alexander J; Ward FE; Ruiz RE; Cresswell P; Dawson JR
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5989-92. PubMed ID: 2068075
[TBL] [Abstract][Full Text] [Related]
69. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
[TBL] [Abstract][Full Text] [Related]
70. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
71. Calreticulin promotes folding of functional human leukocyte antigen class I molecules in vitro.
Culina S; Lauvau G; Gubler B; van Endert PM
J Biol Chem; 2004 Dec; 279(52):54210-5. PubMed ID: 15494401
[TBL] [Abstract][Full Text] [Related]
72. Design and use of conditional MHC class I ligands.
Toebes M; Coccoris M; Bins A; Rodenko B; Gomez R; Nieuwkoop NJ; van de Kasteele W; Rimmelzwaan GF; Haanen JB; Ovaa H; Schumacher TN
Nat Med; 2006 Feb; 12(2):246-51. PubMed ID: 16462803
[TBL] [Abstract][Full Text] [Related]
73. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules.
Di Modugno F; Mammi C; Rosanò L; Rubiu O; Nisticò P; Chersi A
J Immunother; 1997 Nov; 20(6):431-6. PubMed ID: 9409448
[TBL] [Abstract][Full Text] [Related]
74. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
75. Structural comparison of major histocompatibility complex class I molecules and homology modelling of five distinct human leukocyte antigen-A alleles.
Chelvanayagam G; Jakobsen IB; Gao X; Easteal S
Protein Eng; 1996 Dec; 9(12):1151-64. PubMed ID: 9010928
[TBL] [Abstract][Full Text] [Related]
76. Single MHC mutation eliminates enthalpy associated with T cell receptor binding.
Miller PJ; Pazy Y; Conti B; Riddle D; Appella E; Collins EJ
J Mol Biol; 2007 Oct; 373(2):315-27. PubMed ID: 17825839
[TBL] [Abstract][Full Text] [Related]
77. Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR.
Ilca FT; Drexhage LZ; Brewin G; Peacock S; Boyle LH
Cell Rep; 2019 Nov; 29(6):1621-1632.e3. PubMed ID: 31693900
[TBL] [Abstract][Full Text] [Related]
78. Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.
van Luijn MM; van de Loosdrecht AA; Lampen MH; van Veelen PA; Zevenbergen A; Kester MG; de Ru AH; Ossenkoppele GJ; van Hall T; van Ham SM
PLoS One; 2012; 7(4):e34649. PubMed ID: 22563374
[TBL] [Abstract][Full Text] [Related]
79. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.
Barel MT; Hassink GC; van Voorden S; Wiertz EJ
Mol Immunol; 2006 Mar; 43(8):1258-66. PubMed ID: 16098592
[TBL] [Abstract][Full Text] [Related]
80. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.
Garboczi DN; Hung DT; Wiley DC
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3429-33. PubMed ID: 1565634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
